S. Samuelkutty, O. Gluz, G. Schütt, S. Mohrmann, U. Hüttemann, V. Jaspers, J. Huober, N. Harbeck, W. Kuhn, U. Nitz
{"title":"WSG/AGO银行的一项研究:面向1—3淋巴瘤主要淋巴瘤的患者的fe级化疗和发展中国论坛对前者的研究——这是一项在第三阶段的意料外研究","authors":"S. Samuelkutty, O. Gluz, G. Schütt, S. Mohrmann, U. Hüttemann, V. Jaspers, J. Huober, N. Harbeck, W. Kuhn, U. Nitz","doi":"10.1055/S-2006-944440","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"55 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2006-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EC-Doc Studie der WSG/AGO: sequenzielle taxanehaltige Chemotherapie versus 6 x CEF bei Patienten mit primären Mammakarzinom mit 1–3 befallenen Lymphknoten – eine prospektiv randomisierte Phase drei Studie\",\"authors\":\"S. Samuelkutty, O. Gluz, G. Schütt, S. Mohrmann, U. Hüttemann, V. Jaspers, J. Huober, N. Harbeck, W. Kuhn, U. Nitz\",\"doi\":\"10.1055/S-2006-944440\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23881,\"journal\":{\"name\":\"Zentralblatt fur Gynakologie\",\"volume\":\"55 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zentralblatt fur Gynakologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/S-2006-944440\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zentralblatt fur Gynakologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/S-2006-944440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
EC-Doc Studie der WSG/AGO: sequenzielle taxanehaltige Chemotherapie versus 6 x CEF bei Patienten mit primären Mammakarzinom mit 1–3 befallenen Lymphknoten – eine prospektiv randomisierte Phase drei Studie